Adjuvant chemotherapy of colorectal cancer (Q61868117)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083386%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Adjuvant chemotherapy of colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083386%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083386%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Naureen Starling

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083386%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Naureen Starling

series ordinal

2

0 references

language of work or name

English

0 references

publication date

1 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083386%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083386%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

370

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083386%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

9604

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083386%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

1980-1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083386%20AND%20SRC:MED&resulttype=core&format=json

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961841-8

7 January 2021

Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961841-8

7 January 2021

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961841-8

7 January 2021

Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961841-8

7 January 2021

Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961841-8

7 January 2021

Capecitabine as adjuvant treatment for stage III colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961841-8

7 January 2021

Recurrence and survival after total mesorectal excision for rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961841-8

7 January 2021

MRI in predicting curative resection of rectal cancer: new dilemma in multidisciplinary team management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961841-8

7 January 2021

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961841-8

7 January 2021

A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961841-8

7 January 2021

Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961841-8

7 January 2021

Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961841-8

7 January 2021

End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961841-8

7 January 2021

Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961841-8

7 January 2021

Molecular predictors of survival after adjuvant chemotherapy for colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961841-8

7 January 2021

10.1016/S0140-6736(07)61841-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083386%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference